Skip to content
TrialScanner

NCT04492033

A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Phase 1/Phase 2TerminatedCMPXCollaborator

Registry record

Lead sponsor
Handok Inc.
Conditions
P1b: Advanced Solid Tumors; P2: Biliary Tract Cancer
Primary completion
Jan 8, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04492033 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04492033: A Study of CTX-009 (ABL001)... | TrialScanner